383.84

0.87% 3.31

After Hours: 384.05 0.21 +0.05%

Elevance Health Inc (ELV)

Overview News Price History Option Chain Financials Why ELV Down? Discussions Forecast Stock Split Dividend History

Elevance Health Inc stock is traded at $383.84, with a volume of 3.19M. It is up +0.87% in the last 24 hours and down -8.74% over the past month. Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Previous Close:

$380.53

Open:

$379.92

24h Volume:

3.19M

Relative Volume:

1.84

Market Cap:

$86.72B

Revenue:

$183.12B

Net Income/Loss:

$5.92B

P/E Ratio:

14.98

EPS:

25.63

Net Cash Flow:

$3.67B

1W Performance:

+3.11%

1M Performance:

-8.74%

6M Performance:

-5.68%

1Y Performance:

-24.34%

1-Day Range:

$379.32

$389.40

1-Week Range:

$368.83

$389.40

52-Week Range:

$357.45

$567.26

Elevance Health Inc Stock (ELV) Company Profile

Name

Elevance Health Inc

Sector

Healthcare (1170)

Industry

Healthcare Plans (14)

Phone

(800) 331-1476

Address

220 VIRGINIA AVENUE, INDIANAPOLIS

Employee

104,200

Twitter

Next Earnings Date

2025-04-22

Latest SEC Filings

ELV's Discussions on Twitter

Compare ELV with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELV Elevance Health Inc	383.84	86.87B	183.12B	5.92B	3.67B	25.63
UNH Unitedhealth Group Inc	301.91	269.12B	410.06B	22.11B	24.86B	23.88
CI Cigna Group	316.64	83.53B	254.47B	5.03B	6.01B	18.06
CVS Cvs Health Corp	64.04	76.18B	378.96B	5.28B	5.94B	4.19
HUM Humana Inc	233.13	27.41B	117.76B	1.21B	2.39B	9.95

Elevance Health Inc Stock (ELV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-25	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-17-25	Upgrade	Argus	Hold → Buy
Jan-22-25	Downgrade	Stephens	Overweight → Equal-Weight
Oct-18-24	Downgrade	Argus	Buy → Hold
Jul-18-24	Downgrade	BofA Securities	Buy → Neutral
Jun-24-24	Initiated	Morgan Stanley	Overweight
May-30-24	Initiated	Robert W. Baird	Outperform
Mar-06-24	Initiated	Barclays	Overweight
Jul-12-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Mar-28-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Sep-09-22	Upgrade	BofA Securities	Neutral → Buy
Aug-22-22	Upgrade	SVB Leerink	Mkt Perform → Outperform

View All

Elevance Health Inc Stock (ELV) Latest News

01:45 AM

DEADLINE ALERT for WST, DMRC, CODI, ELV: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.

01:45 AM

11:48 AM

Cantor Fitzgerald Reiterates ‘Overweight’ Rating on Elevance Health (ELV) - Insider Monkey

11:48 AM

10:20 AM

ELV Investors Have the Opportunity to Lead the Elevance Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - The Victoria Advocate

10:20 AM

May 29, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance - GlobeNewswire

May 29, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - TradingView

May 29, 2025